Savage DB - Search Results

1

Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice.

Patel S, Haider A, Alvarez-Guaita A, Bidault G, El-Sayed Moustafa JS, Guiu-Jurado E, Tadross JA, Warner J, Harrison J, Virtue S, Scurria F, Zvetkova I, Blüher M, Small KS, O'Rahilly S, Savage DB. Patel S, et al. Among authors: savage db. Mol Metab. 2022 Nov;65:101589. doi: 10.1016/j.molmet.2022.101589. Epub 2022 Sep 2. Mol Metab. 2022. PMID: 36064109 Free PMC article.

2

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans.

Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S. Savage DB, et al. Diabetes. 2001 Oct;50(10):2199-202. doi: 10.2337/diabetes.50.10.2199. Diabetes. 2001. PMID: 11574398

3

Leptin: a novel therapeutic role in lipodystrophy.

Savage DB, O'Rahilly S. Savage DB, et al. J Clin Invest. 2002 May;109(10):1285-6. doi: 10.1172/JCI15326. J Clin Invest. 2002. PMID: 12021242 Free PMC article. No abstract available.

4

Isomer-dependent metabolic effects of conjugated linoleic acid: insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha.

Roche HM, Noone E, Sewter C, Mc Bennett S, Savage D, Gibney MJ, O'Rahilly S, Vidal-Puig AJ. Roche HM, et al. Diabetes. 2002 Jul;51(7):2037-44. doi: 10.2337/diabetes.51.7.2037. Diabetes. 2002. PMID: 12086931

5

The metabolic syndrome: peroxisome proliferator-activated receptor gamma and its therapeutic modulation.

Gurnell M, Savage DB, Chatterjee VK, O'Rahilly S. Gurnell M, et al. Among authors: savage db. J Clin Endocrinol Metab. 2003 Jun;88(6):2412-21. doi: 10.1210/jc.2003-030435. J Clin Endocrinol Metab. 2003. PMID: 12788836 Review.

6

Energy expenditure and adaptive responses to an acute hypercaloric fat load in humans with lipodystrophy.

Savage DB, Murgatroyd PR, Chatterjee VK, O'Rahilly S. Savage DB, et al. J Clin Endocrinol Metab. 2005 Mar;90(3):1446-52. doi: 10.1210/jc.2004-1494. Epub 2004 Dec 21. J Clin Endocrinol Metab. 2005. PMID: 15613417 Clinical Trial.

7

TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.

Loos RJ, Franks PW, Francis RW, Barroso I, Gribble FM, Savage DB, Ong KK, O'Rahilly S, Wareham NJ. Loos RJ, et al. Among authors: savage db. Diabetes. 2007 Jul;56(7):1943-7. doi: 10.2337/db07-0055. Epub 2007 Apr 6. Diabetes. 2007. PMID: 17416797 Free PMC article.

8

A clinical approach to severe insulin resistance.

Savage DB, Semple RK, Chatterjee VKK, Wales JKH, Ross RJM, O'Rahilly S. Savage DB, et al. Endocr Dev. 2007;11:122-132. doi: 10.1159/000111067. Endocr Dev. 2007. PMID: 17986832 Review.

9

Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance.

Semple RK, Cochran EK, Soos MA, Burling KA, Savage DB, Gorden P, O'Rahilly S. Semple RK, et al. Among authors: savage db. Diabetes Care. 2008 May;31(5):977-9. doi: 10.2337/dc07-2194. Epub 2008 Feb 25. Diabetes Care. 2008. PMID: 18299442

10

Fatty acid metabolism in patients with PPARgamma mutations.

Tan GD, Savage DB, Fielding BA, Collins J, Hodson L, Humphreys SM, O'Rahilly S, Chatterjee K, Frayn KN, Karpe F. Tan GD, et al. Among authors: savage db. J Clin Endocrinol Metab. 2008 Nov;93(11):4462-70. doi: 10.1210/jc.2007-2356. Epub 2008 Aug 19. J Clin Endocrinol Metab. 2008. PMID: 18713822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page